Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS
International Journal of Molecular Sciences · 03.02.2024 · 25 (3) · 1871
DOI: 10.3390/ijms25031871 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2024. Verfasst von Aven Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Research, The University of Queensland, Brisbane, QLD 4029, Australia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wesley Medical Research, MND Research Australia, Motor Neuron Disease Research Institute of Australia.
Abstract (Originalsprache)
Many pathogenetic mechanisms have been proposed for amyotrophic lateral sclerosis (ALS). Recently, there have been emerging suggestions of a possible role for the gut microbiota. Gut microbiota have a range of functions and could influence ALS by several mechanisms. Here, we review the possible role of gut-derived neurotoxins/excitotoxins. We review the evidence of gut symptoms and gut dysbiosis in ALS. We then examine a possible role for gut-derived toxins by reviewing the evidence that these molecules are toxic to the central nervous system, evidence of their association with ALS, the existence of biochemical pathways by which these molecules could be produced by the gut microbiota and existence of mechanisms of transport from the gut to the blood and brain. We then present evidence that there are increased levels of these toxins in the blood of some ALS patients. We review the effects of therapies that attempt to alter the gut microbiota or ameliorate the biochemical effects of gut toxins. It is possible that gut dysbiosis contributes to elevated levels of toxins and that these could potentially contribute to ALS pathogenesis, but more work is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Clinical Research, The University of Queensland, Brisbane, QLD 4029, Australia.
- Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, QLD 4029, Australia.
- Wesley Research Institute, The Wesley Hospital, Auchenflower, QLD 4066, Australia.
Förderung
- Wesley Medical Research
- MND Research Australia
- Motor Neuron Disease Research Institute of Australia
Zitieren
APA
Lee, A., Henderson, R., Aylward, J., & McCombe, P. (2024). Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS. International Journal of Molecular Sciences, 25(3), 1871. https://doi.org/10.3390/ijms25031871
Vancouver
Lee A, Henderson R, Aylward J, McCombe P. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS. International Journal of Molecular Sciences. 2024;25(3):1871. doi:10.3390/ijms25031871
BibTeX
@article{Lee2024,
author = {Lee, Aven and Henderson, Robert and Aylward, James and McCombe, Pamela},
title = {Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1871},
doi = {10.3390/ijms25031871}
}
EUVIMED